Fuente | Nº Citas | Fecha Actualización |
---|---|---|
scopus | 3401 | 29-10-2024 |
wos | 3128 | 29-10-2024 |
Año: 2014
Journal Impact Factor (JIF): 55.8730
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
MEDICINE, GENERAL & INTERNAL | SCIE | 1/154 | Q1 | T1 | D1 |
Año: 2017
Journal Citation Indicator (JCI): 23,770
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
MEDICINE, GENERAL & INTERNAL | 1/298 | Q1 | T1 | D1 | 99,83 |
Año:
2014
CiteScore:
57,300
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
General Medicine | 7/3264 | Q1 | T1 | D1 |
SJR año:
2014
Factor de Impacto:
16,259
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Medicine (miscellaneous) | 5/2859 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
Abbott | - |
Actelion | - |
Altitude Pharma | - |
Amgen | - |
Asahi Kasei Pharma | - |
AstraZeneca | - |
Bayer | - |
Biogen Idec | - |
Biogen-Stromedix | - |
Boehringer Ingelheim | - |
Bristol-Myers Squibb | - |
Celgene | - |
Centocor | - |
Chugai | - |
Eisai | - |
Eli Lilly | - |
Excel | - |
FibroGen | - |
Forest | - |
France Foundation | - |
Fukuda Denshi | - |
Galecto | - |
Genentech | - |
Gilead | - |
GlaxoSmithKline | - |
Harefield NHS Foundation Trust | - |
Ikaria | - |
ImmuneWorks | - |
Imperial College London | - |
InterMune | - |
Kyorin | - |
Matrix | - |
MedImmune | - |
Meiji Seika Pharma | - |
Mesoblast | - |
Moerae | - |
Moerae Matrix | - |
National Institute for Health Research | NF-SI-0512-10157 |
National Institute for Health Research (NIHR) Southampton Respiratory Biomedical Research Unit at the University Hospital Southampton NHS Foundation Trust | - |
NIHR Respiratory Disease Bio-medical Research Unit at the Royal Brompton | - |
Novartis | - |
Olympus | - |
Ono Pharmaceutical | - |
Pfizer | - |
Philips Respironics | - |
Promedior | - |
Roche | - |
Roche-Genentech | - |
Sanofi-Aventis | - |
Sanofi-Genzyme | - |
Shionogi | - |
Taiho Pharmaceutical | - |
Takeda | - |
Teijin Pharma | - |
Terumo | - |
Veracyte | - |
Vertex | - |
# | Autor | Afiliación |
---|---|---|
1 | University Hospital Southampton NHS Foundation Trust (United Kingdom) | |
2 | Du Bois, Roland M. | Imperial College London (United Kingdom) |
3 | Raghu, Ganesh | University of Washington, Seattle (United States) |
4 | Azuma, Arata | Nippon Medical School (Japan) |
5 | Brown, Kevin K. | National Jewish Health (United States) |
6 | Costabel, Ulrich | Universitäts Klinikum Essen und Medizinische Fakultät (Germany) |
7 | Cottin, Vincent | Université de Lyon (France) |
8 | Flaherty, Kevin R. | Michigan Medicine (United States) |
9 | Hansell, David M. | Royal Brompton and Harefield NHS Trust (United Kingdom) |
10 | Inoue, Yoshikazu | National Hospital Organization, Japan (Japan) |
11 | Kim, Dong Soon | Ulsan University (South Korea) |
12 | Kolb, Martin | McMaster University (Canada) |
13 | Nicholson, Andrew G. | Royal Brompton and Harefield NHS Trust (United Kingdom) |
14 | Noble, Paul W. | Cedars-Sinai Medical Center (United States) |
15 | Selman, Moisés | Instituto Nacional de Enfermedades Respiratorias (Mexico) |
16 | Taniguchi, Hiroyuki | Tosei General Hospital (Japan) |
17 | Brun, Michèle | Boehringer Ingelheim France S.A.S. (France) |
18 | Le Maulf, Florence | Boehringer Ingelheim France S.A.S. (France) |
19 | Girard, Mannaïg | Boehringer Ingelheim France S.A.S. (France) |
20 | Stowasser, Susanne | Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) |
21 | Schlenker-Herceg, Rozsa | Boehringer Ingelheim Pharmaceuticals, Inc. (United States) |
22 | Disse, Bernd | Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) |
23 | Collard, Harold R. | University of California, San Francisco (United States) |
# | Autoría grupal | Afiliación |
1 | Alfageme Michavila, Inmaculada (INPULSIS Trial Investigators) | Sin datos () |